Skip to main content
. 2015 May 29;4(12):e1051297. doi: 10.1080/2162402X.2015.1051297

Figure 4.

Figure 4.

High doses of anti-CTLA-4 mAb can completely abrogate (T)cell suppression mediated by tumor-infiltrating Treg. The effect of higher doses of anti-CTLA-4 mAb on Treg-mediated suppression was tested using lymphocytes isolated from three different LM-CRC patients. T cell proliferation analysis revealed that higher doses of the neutralizing anti-CTLA-4 antibody are able to completely abolish the suppression mediated by tumor-infiltrating Treg.